Volume : 12, Issue : 06, June – 2025
Title:
FORMULATION AND EVALUATION OF GEMCITABINE NIOSOMAL DRUG DELIVERY SYSTEM
Authors :
G. Harikiriti Varma*, Vijaya Kuchana, E. Akshaya, E. Nandulal, E. Ankitha, G. Sai charan, G. Jyoshna
Abstract :
The present study was focused on formulating and evaluating Gemcitabine containing niosomes formulation for invitro studies. Niosomal formulations were prepared by using different ratio of surfactant (Tween 40 and Span 80) and cholesterol by thin film hydration method and were evaluated for in vitro characteristics, stability studies. Span 80 containing niosomal formulation displayed highest entrapment efficiency with desired particle size. SEM analyses showed that niosomal formulation was spherical in shape. Niosomes containing Span 80 displayed higher percentage of drug release after 8h as compared to other formulations. F-4 formulation was found to be stable at the end of the study on storage condition. The present study suggested that niosomal formulations provide sustained and prolonged delivery of drug with enhance bioavailability.
Keywords: Niosomes, Gemcitabine, bioavailability, thin film hydration technique, in vitro drug release studies.
Cite This Article:
Please cite this article in press G. Harikiriti Varma et al., Formulation And Evaluation Of Gemcitabine Niosomal Drug Delivery System.., Indo Am. J. P. Sci, 2025; 12(07).
Number of Downloads : 10
References:
1. Lordi, N.G. Sustained release dosage forms. In: Lachman, L., Lieberman, H.A. and Kanig, J.L. (eds.) The theory and practice of industrial pharmacy, 3rd edn (Indian edn). Varghese Publishing House, Bombay, 1987; 430–456.
2. Ertekin Z., Bayindir Z., Yuksel N. Stability Studies on Piroxicam Encapsulated Niosomes. Curr Drug Deliv. 2015; 12:192–199.
3. Saraf S., Ankit J., Tiwari A., Verma A., Pandaa P.K., Jain S.K. Advances in liposomal drug delivery to cancer: An overview. J. Drug Deliv. Sci. Technol. 2020; 56:101549.
4. Weissman G, Bloomgarden D, Kaplan R, Cohen C, Hoffstein S, Collins T, et al. A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells. Proc Natl Acad Sci 1975;72:88-92
5. E. Mini, Cellular pharmacology of gemcitabine, Ann. Oncol. (2006)
6. Mazayen Z.M., Ghoneim A.M., Elbatanony R.S., Basalious E.B., Bendas E.R. Pharmaceutical nanotechnology: From the bench to the market. Future J. Pharm. Sci. 2022;8:12.
7. Sahani S., Sharma Y.C. Advancements in applications of nanotechnology in global food industry. Food Chem. 2021;342:128318.
8. Thatyana M., Dube N.P., Kemboi D., Manicum A.-L.E., Mokgalaka-Fleischmann N.S., Tembu J.V. Advances in Phytonanotechnology: A Plant-Mediated Green Synthesis of Metal Nanoparticles Using Phyllanthus Plant Extracts and Their Antimicrobial and Anticancer Applications. Nanomaterials. 2023;13:2616.
9. Bayda S., Adeel M., Tuccinardi T., Cordani M., Rizzolio F. The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine. Molecules. 2020;25:112.
10. Soni R.A., Rizwan M.A., Singh S. Opportunities and potential of green chemistry in nanotechnology. Nanotechnol. Environ. Eng. 2022;7:661–673.
11. Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B. 2003;30:129–38.
12. Balasubramaniam A, Kumar VA, Pillai KS. Formulation and in-vivo evaluation of niosome encapsulated daunorubicin hydrochloride. Drug Dev Ind Pharm. 2002;28:1181–93.
13. Yoshioka T, Stermberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sobitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85) Int J Pharm. 1994;105:1–6.
14. Karki R, Mamatha GC, Subramanya G, Udupa N. Preparation, characterization and tissue disposition of niosomes containing isoniazid. Rasayan J Chem. 2008;1:224–7.
15. Hunter CA, Dolan TF, Coombs GH, Baillie AJ. Vesicular system (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharm Pharmacol. 1988;40:161–5.